These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 34678322)

  • 21. Large-scale analysis of B-cell epitopes of envelope: Implications for Zika vaccine and immunotherapeutic development.
    Almansour I; Alfares R; Aljofi H
    F1000Res; 2018; 7():1624. PubMed ID: 31316749
    [No Abstract]   [Full Text] [Related]  

  • 22. Mechanism of differential Zika and dengue virus neutralization by a public antibody lineage targeting the DIII lateral ridge.
    Zhao H; Xu L; Bombardi R; Nargi R; Deng Z; Errico JM; Nelson CA; Dowd KA; Pierson TC; Crowe JE; Diamond MS; Fremont DH
    J Exp Med; 2020 Feb; 217(2):. PubMed ID: 31757867
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rational Engineering and Characterization of an mAb that Neutralizes Zika Virus by Targeting a Mutationally Constrained Quaternary Epitope.
    Tharakaraman K; Watanabe S; Chan KR; Huan J; Subramanian V; Chionh YH; Raguram A; Quinlan D; McBee M; Ong EZ; Gan ES; Tan HC; Tyagi A; Bhushan S; Lescar J; Vasudevan SG; Ooi EE; Sasisekharan R
    Cell Host Microbe; 2018 May; 23(5):618-627.e6. PubMed ID: 29746833
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Investigation of the immunogenicity of Zika glycan loop.
    Henderson EA; Tam CC; Cheng LW; Ngono AE; Nguyen AV; Shresta S; McGee M; Padgett H; Grill LK; Martchenko Shilman M
    Virol J; 2020 Mar; 17(1):43. PubMed ID: 32234060
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dengue and Zika Virus Domain III-Flagellin Fusion and Glycan-Masking E Antigen for Prime-Boost Immunization.
    Lin HH; Yang SP; Tsai MJ; Lin GC; Wu HC; Wu SC
    Theranostics; 2019; 9(16):4811-4826. PubMed ID: 31367259
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Zika Virus Envelope Protein and Antibody Complexes.
    Dai L; Wang Q; Song H; Gao GF
    Subcell Biochem; 2018; 88():147-168. PubMed ID: 29900496
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structure and neutralization mechanism of a human antibody targeting a complex Epitope on Zika virus.
    Adams C; Carbaugh DL; Shu B; Ng TS; Castillo IN; Bhowmik R; Segovia-Chumbez B; Puhl AC; Graham S; Diehl SA; Lazear HM; Lok SM; de Silva AM; Premkumar L
    PLoS Pathog; 2023 Jan; 19(1):e1010814. PubMed ID: 36626401
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adjacent dimer epitope of envelope protein as an important region for Zika virus serum neutralization: a computational investigation.
    Fuzo CA; de Araujo LFL; Pontes RS; Évora PM; Stabeli RG
    J Biomol Struct Dyn; 2021 Feb; 39(3):1082-1092. PubMed ID: 32090677
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of two engineered dimeric Zika virus envelope proteins as immunogens for neutralizing antibody selection and vaccine design.
    Yang C; Zeng F; Gao X; Zhao S; Li X; Liu S; Li N; Deng C; Zhang B; Gong R
    J Biol Chem; 2019 Jul; 294(27):10638-10648. PubMed ID: 31138647
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human antibody response to Zika targets type-specific quaternary structure epitopes.
    Collins MH; Tu HA; Gimblet-Ochieng C; Liou GA; Jadi RS; Metz SW; Thomas A; McElvany BD; Davidson E; Doranz BJ; Reyes Y; Bowman NM; Becker-Dreps S; Bucardo F; Lazear HM; Diehl SA; de Silva AM
    JCI Insight; 2019 Apr; 4(8):. PubMed ID: 30996133
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structural basis of a potent human monoclonal antibody against Zika virus targeting a quaternary epitope.
    Long F; Doyle M; Fernandez E; Miller AS; Klose T; Sevvana M; Bryan A; Davidson E; Doranz BJ; Kuhn RJ; Diamond MS; Crowe JE; Rossmann MG
    Proc Natl Acad Sci U S A; 2019 Jan; 116(5):1591-1596. PubMed ID: 30642974
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of Two Highly Specific Monoclonal Antibodies Targeting the Glycan Loop of the Zika Virus Envelope Protein.
    McLaury AR; Haun BK; To A; Mayerlen L; Medina LO; Lai CY; Wong TAS; Nakano E; Strange D; Aquino D; Huang YS; Higgs S; Vanlandingham DL; Garcia A; Berestecky JM; Lehrer AT
    Viral Immunol; 2024 Apr; 37(3):167-175. PubMed ID: 38574259
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neutralization of Zika virus by E protein domain III-Specific human monoclonal antibody.
    Kim SI; Kim S; Shim JM; Lee HJ; Chang SY; Park S; Min JY; Park WB; Oh MD; Kim S; Chung J
    Biochem Biophys Res Commun; 2021 Mar; 545():33-39. PubMed ID: 33535104
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A method for mapping the linear epitopes targeted by the natural antibody response to Zika virus infection using a VLP platform technology.
    Fowler A; Ye C; Clarke EC; Pascale JM; Peabody DS; Bradfute SB; Frietze KM; Chackerian B
    Virology; 2023 Feb; 579():101-110. PubMed ID: 36623351
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Preparation of monoclonal antibodies against the envelope protein extracellular domain of Zika virus in mice].
    Xue P; Dong Y; Wu F; Chen Y; Zhang J; Yuan H; Wu S; Yuan R; Li B; Lei Y
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2024 May; 40(5):447-454. PubMed ID: 38790101
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optimization of Zika virus envelope protein production for ELISA and correlation of antibody titers with virus neutralization in Mexican patients from an arbovirus endemic region.
    Kim YC; Lopez-Camacho C; Nettleship JE; Rahman N; Hill ML; Silva-Reyes L; Ortiz-Martinez G; Figueroa-Aguilar G; Mar MA; Vivanco-Cid H; Rollier CS; Zitzmann N; Viveros-Sandoval ME; Owens RJ; Reyes-Sandoval A
    Virol J; 2018 Dec; 15(1):193. PubMed ID: 30587198
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potent Zika and dengue cross-neutralizing antibodies induced by Zika vaccination in a dengue-experienced donor.
    Dussupt V; Sankhala RS; Gromowski GD; Donofrio G; De La Barrera RA; Larocca RA; Zaky W; Mendez-Rivera L; Choe M; Davidson E; McCracken MK; Brien JD; Abbink P; Bai H; Bryan AL; Bias CH; Berry IM; Botero N; Cook T; Doria-Rose NA; Escuer AGI; Frimpong JA; Geretz A; Hernandez M; Hollidge BS; Jian N; Kabra K; Leggat DJ; Liu J; Pinto AK; Rutvisuttinunt W; Setliff I; Tran U; Townsley S; Doranz BJ; Rolland M; McDermott AB; Georgiev IS; Thomas R; Robb ML; Eckels KH; Barranco E; Koren M; Smith DR; Jarman RG; George SL; Stephenson KE; Barouch DH; Modjarrad K; Michael NL; Joyce MG; Krebs SJ
    Nat Med; 2020 Feb; 26(2):228-235. PubMed ID: 32015557
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recombinant Chimpanzee Adenovirus Vaccine AdC7-M/E Protects against Zika Virus Infection and Testis Damage.
    Xu K; Song Y; Dai L; Zhang Y; Lu X; Xie Y; Zhang H; Cheng T; Wang Q; Huang Q; Bi Y; Liu WJ; Liu W; Li X; Qin C; Shi Y; Yan J; Zhou D; Gao GF
    J Virol; 2018 Mar; 92(6):. PubMed ID: 29298885
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Two immunogenic recombinant protein vaccine candidates showed disparate protective efficacy against Zika virus infection in rhesus macaques.
    Yang R; Liu Q; Pang W; Gao F; Liang H; Zhang W; Lin Y; Li M; Liu Z; Gao GF; Zhang L; Xiao H; Zheng Y; Huang Z; Jin X
    Vaccine; 2021 Feb; 39(6):915-925. PubMed ID: 33451779
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection.
    Stettler K; Beltramello M; Espinosa DA; Graham V; Cassotta A; Bianchi S; Vanzetta F; Minola A; Jaconi S; Mele F; Foglierini M; Pedotti M; Simonelli L; Dowall S; Atkinson B; Percivalle E; Simmons CP; Varani L; Blum J; Baldanti F; Cameroni E; Hewson R; Harris E; Lanzavecchia A; Sallusto F; Corti D
    Science; 2016 Aug; 353(6301):823-6. PubMed ID: 27417494
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.